Skip to main content
. Author manuscript; available in PMC: 2014 Dec 2.
Published in final edited form as: Transl Res. 2014 Jun 17;164(5):424–432. doi: 10.1016/j.trsl.2014.06.003

Fig 2.

Fig 2

Angiotensin II antagonism reverses increased CSA in diabetes. A. CSA across the pressure range is increased in diabetic GK rats and azilsartan medoxomil treatment lowers CSA in diabetes as well as in control animals (*p<0.05 vs other groups). B. CSA at 100 mmHg pressure point is greater in GK rats and treatment reduces it both control and diabetic animals (*p<0.05 vs Wis, #p<0.05 vs untreated). C. β-coefficient was greater in diabetic animals indicating stiffer vessels (*p<0.05 vs Wis, #p<0.05 vs vehicle, **p=0.0084; disease treatment interaction). Values are mean ± SEM, n=6–8/group.